CP382 - Intermittent Catheter (IC) PRO Panel Plan
← catalyst calendarNCT07475468 · readout in 2,234 d
Sponsored by Coloplast A/S (industry) · COLO-B.CO — their whole pipeline →. With IQVIA Pty Ltd.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
1,000estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-01 | estimated | When the study began enrolling |
| Primary completion | 2032-09-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2032-10-31 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-13 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Intermittent Catheterization
Intervention
- Other: No Intervention: Observational Cohort
Primary outcomes
what the primary-completion date above is the date OFNumber of IC products used by subjects.
measured 5 years
The number of urinary tract infections
measured 5 years
The Mental well-being index (WHO-5)
measured 5 years
Publications
- PMID 27053002 — cited as background
- PMID 28699993 — cited as background
- PMID 39261137 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · COLO-B.CO's whole pipeline · Catalyst calendar · Every registered study · What changed